Keywords: pharmos, begin, ph, ii, neuroprotector, corporation, israel

Pharmos To Begin Ph II With Neuroprotector

Article | 25 November 1996

Print This

Pharmos Corporation of Israel has received approval from the Israeli Minister of Health to commence a Phase II study with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in